Enhancing Prospective Thinking in Early Recovery
B
Brandon Oberlin
Primary Investigator
Recruiting
18-100 years
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to better understand what factors, demographic characteristics, and interventions predict better recovery-related outcomes.
Detailed description of study
If you are in early recovery and are interested in participating, we will contact you to conduct a preliminary phone screen to see if you are eligible for any of our currently running studies. The phone screen takes between 10-20 minutes.
If you could potentially qualify for any of our studies based on the phone screen, we will schedule you for a more comprehensive clinical interview located at the Indiana Clinical Research Center (ICRC, 5th floor of Goodman Hall, 355 W. 16th Street, Indianapolis, IN 46202). Our clinical interviews could take up to 4 hours, but you will be compensated $20 for your time.
If you continue to qualify past the clinical interview, we will schedule your study day visit, which could take up to 8 hours, depending on what study you are eligible to participate in. Compensation for study participation varies but could be compensated up to $230 for your study participation.
Please call our study line or fill out our pre-screen at:
(317) 278-5012 OR https://is.gd/vrrecoverystudy
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Addiction recovery,Addiction,recovery,addiction,1805574553,recovery,addiction
-
Age: Between 18 Years - 100 Years
-
Gender: All
Men and women in early recovery from alcohol or substance use (recently released from detox, and/or inpatient treatment, and/or currently in outpatient addiction treatment).
Participants who have remained drug/alcohol free since treatment.
Able to understand questionnaires/procedures in English.
Able to understand questionnaires/procedures in English.
Must be at least 18 years old to participate.
Participants will be paid for their participation.
Updated on
01 Aug 2024.
Study ID: 1805574553
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
A copy of the message has been sent to your email
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
